• Home >>
  • Pharmaceuticals and Healthcare >>
  • Cervical Cancer Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Cervical Cancer Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240343 21st May, 2018 Region : Global Pages Reports Monitor

Global Cervical Cancer Treatment Market by type (Squamous Cell Carcinomas, Adenocarcinomas, Adenosquamous Carcinomas), by treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), by end-User (Cancer Care Centers) –Forecast Till 2025.


The lower part of uterus that connects to vagina is cervix. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), generally a sexually transmitted antigen, are the general cause of cervical cancer. The disease begins when healthy cells acquire mutation leading to the uncontrolled growth of cells. These cells form a tumor which invades the nearby tissues. There are different types of cervical cancer such as Squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas. Squamous cell carcinomas develop from cells in the exocervix while adenocarcinomas develop from gland cells. There are different methods for treatment of cervical cancer; cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, and trachelectomy are some of the commonly used treatment.


The major driver of cervical cancer treatment market is increase in prevalence of cervical cancer and growing awareness of cervical cancer in women. As per WHO, cervical cancer accounts for 3.7% of all the cancers. In 2012, 528,000 women were diagnosed with cervical cancer. Additionally, over use of oral contraceptives and smoking both active & passive increases the chance of cervical cancer. Even multiple pregnancies increases the risk of cervical cancer. However, the growing demand of early diagnosis and advancement in treatment procedures will also fuel the growth of the market.


However, the high cost of treatment is a major restraint for the growth of the market.


Moreover, the growing research & development in healthcare sector and increasing funding for improving medical facilities is pushing forward the market.


Key players:

Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Eli Lilly and Company, Alnylam Pharmaceuticals, Inc, Hetero, Biocon, Novartis, Genentech USA, ALLERGAN, Actavis Pharma Company are the key players of market.


Market segmentation:

The cervical cancer treatment market is segmented on the basis of type, treatment, end user and region.


Based on type it is further classified as squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas.


On the basis of treatment the market is segmented as surgery, radiation therapy, chemotherapy, targeted therapy, hormone therapy, and others. Surgery is further sub segmented as cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, trachelectomy, and others. Radiation Therapy is further segmented into external beam radiation and brachytherapy. Chemotherapy is further segmented into cisplatin, carboplatin, paclitaxel, doxorubicin, gemcitabine, bevacizumab, and others.


Based on end user the market is segmented as hospitals, cancer cares, diagnostic centres and others.


Regional analysis:

Regionally the market is segmented into North America, Europe, Asia pacific and Latin America, Middle East & Africa.


North America holds the largest share of market owing to their advancement in technology in field of oncology. The changing lifestyle of women in North America is increasing the patient pool in North America. As per America cancer society, U.S is expected to have more than 13000 new cervical patients this year.


Europe has the second largest market, the growth of the market is attributed to a number of healthcare institutions offering treatment of cancer and huge investments in research and development activities by the U.K. and Germany. In Germany, the market is mainly driven by an increase in the use of new technological devices for the diagnosis and treatment of cancer.


Asia pacific region is expected to have fastest growth during the forecast period. This region has several growth opportunities and the growing awareness about treatment of cervical cancer is driving the market. Additionally, countries like India and China are paying heed on early diagnosis of the disease and cost effective treatment of disease. The growing government support in healthcare of the region is also fueling the growth of the market


LAMEA has the least share of the market, although number of patient of cervical cancer is maximum in this region. Middle is the major contributor of the region as they are financially sound also African countries are taking initiatives in healthcare which will boost the market growth.


Global segmentation:


• By type

o Squamous cell carcinomas

o Adenocarcinomas

o Adenosquamous carcinomas.


• By treatment

o Surgery

 Cryosurgery

 laser surgery

 simple hysterectomy

 radical hysterectomy 

 trachelectomy

 others


o radiation therapy

o chemotherapy

 cisplatin, carboplatin

 paclitaxel

 doxorubicin

 gemcitabine

 bevacizumab

 others


o targeted therapy

o hormone therapy

o others


• By end user

o Hospitals 

o cancer cares

o diagnostic centres 

o others


• By Geography


o North America

 U.S.

 Canada

 Mexico


o Europe

 UK

 Germany

 France

 Italy

 Spain

 Rest of Europe


o Asia-Pacific

 China

 India

 Japan

 South Korea

 Australia

 Rest of Asia-Pacific


o LAMEA

 Brazil

 Saudi Arabia

 South Africa

 Rest of LAMEA

Research Scope 

The study for Global cervical cancer Market Survey and Trend Research 2018 will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2017  Forecast: 2018 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 


Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 


4. End use Overview

4.1. Introduction 

4.2. Market Size & Forecast, 2015 to 2025

4.3. By end user

4.3.1. Hospitals, cancer care

4.3.2. Diagnostic centres 

4.3.3. Others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Regional Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. North America

5.2.1.1. U.S.

5.2.1.2. Canada

5.2.1.3. Mexico 

5.2.2. Europe

5.2.2.1. UK

5.2.2.2. Germany

5.2.2.3. France

5.2.2.4. Italy 

5.2.2.5. Russia

5.2.2.6. Poland

5.2.2.7. Rest of Europe

5.2.3. Asia-Pacific

5.2.3.1. China

5.2.3.2. India

5.2.3.3. Japan

5.2.3.4. Australia

5.2.3.5. South Korea

5.2.3.6. Rest of Asia-Pacific

5.2.4. LAMEA

5.2.4.1. Saudi Arabia

5.2.4.2. UAE

5.2.4.3. South Africa

5.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Manufacturer/ Vendor Profile

6.1. The following attributes will be considered while profiling key manufacturers in this industry: 

6.1.1.1. Company Overview

6.1.1.2. Financial Synopsis

6.1.1.3. Recent Developments

6.1.1.4. R&D Investments (if any)

6.1.1.5. Strategy Overview (Analyst Perspective)

6.1.1.6. Product Portfolio

6.2. Companies Profiled

6.2.1. Pfizer Inc.

6.2.2. GlaxoSmithKline

6.2.3. Bristol-Myers Squibb Company

6.2.4. Eli Lilly and Company

6.2.5. Alnylam Pharmaceuticals, Inc, 

6.2.6. Hetero

6.2.7. Biocon

6.2.8. Novartis

6.2.9. Genentech USA

6.2.10. ALLERGAN

6.2.11. Actavis Pharma Company

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]